WHAT ARE COVID19Ab RAPID TEST LIMITATIONS?
The COVID19 Ab test is for in vitro diagnostic use only. This test should be used for the detection of IgG and IgM antibody to SARS-CoV-2 in whole blood, serum or plasma specimens. Neither the quantitative value nor the rate of increase in the concentration of IgG or IgM antibodies to SARS- CoV-2 can be determined by this qualitative test.
The COVID19 Ab test will only indicate the presence of IgG and IgM antibodies to the SARS-CoV-2 virus in the specimen and should NOT be used as the sole criteria for the diagnosis of COVID19infections.
A negative result for an individual subject indicates the absence of detectable anti-COVID-19 antibodies. However, a negative test result does not preclude the possibility of exposure to or infection with COVID-19. A negative result can occur if the quantity of the anti-COVID-19 antibodies present in the specimen is below the detection limits of the assay, or the antibodies that are detected are not present during the stage of disease in which a sample is collected.
The hematocrit level of the whole blood can affect the test results. Hematocrit level needs to be between 25% and 65% for accurate results.
As with all diagnostic tests, all results must be considered with other clinical information available to the physician.SCHEDULE NOW